Merrimack Pharmaceuticals, Inc.401(k)

Merrimack Pharmaceuticals, Inc. reported $19,501 in plan administrative expenses for 2023: 0.14% of average plan assets, below the peer median. This ratio covers administrative expenses reported on the plan's Schedule H only; fund-level expense ratios are not included in public structured data — see methodology.

Across the 2 years on file its reported administrative ratio fell from 0.04% to 0.00%. The plan sits in the $10M–$50M size bracket, benchmarked here against 26,779 comparable plans and shown alongside other manufacturing employers. By assets it is among the smaller plans on file in Massachusetts (1,567th of 2,726), and 7,251st of 13,661 in manufacturing.